The immunomodulatory effects of opioids are known in various infections. However, little is known about the effects of opioids in tuberculosis (TB). In the present study, we report the effects of morphine in Mycobacterium smegmatis infection in mice and macrophages. Morphine exerted a dose-dependent suppression of infection in vivo: 50 and 100 mg/kg morphine exerted signifi cant (P<0.05) suppression whereas 5 mg/kg morphine showed no effect. Analogous to the in vivo effects, incubation of M. smegmatis -infected mouse peritoneal macrophages with morphine (100 μM) showed signifi cant reduction in intramacrophage CFU counts. However, morphine did not show any direct antimycobacterial activity in broth dilution assay upto 100 μM concentration. Further, morphine-induced intramacrophage killing of M. smegmatis was abrogated by naloxone and aminoguanidine indicating the involvement of opioidreceptor activation and nitric oxide production in protective effects of morphine. In conclusion, morphine suppressed the progression of experimental TB in both mice and macrophage models.
Introduction
Opioids comprise an important pharmacological class of analgesics which act by binding to G-protein coupled opioid receptors. Long before opioids were discovered, their addictive potential was identifi ed. However, the effects of opioids on the immune system were realized in the 20th century [1] . Opioids exert immunomodulatory effects by direct and indirect mechanisms. The direct effects of opioids result from activation of opioid receptors expressed by immune cells which lead to alterations in various physiological functions of immune cells. On the other hand, the indirect effects of opioids are mediated through the central nervous system and involve activation of hypothalamuspituitary-adrenal axis [2] [3] [4] . Clinically, patients receiving chronic opioid therapy and opioid addicts exhibit alterations in immune functions predisposing them to infections [1, 4] . Experimental studies suggest that chronic exposure to morphine leads to suppression of normal cellular functions of immune cells, particularly macrophages and lymphocytes [2, 5] .
Despite several reports demonstrating the immunosuppressive effects of morphine, the immunostimulatory effects of morphine have also been documented. Morphine can augment protective immune responses, both in vitro and in vivo, leading to suppression of infection [6] [7] [8] . The effects observed are dose-dependent and biphasic in nature [8] [9] [10] [11] .
Clinical studies show that opioid addicts are relatively more susceptible to mycobacterial infections than non-addicts [12] and also show reduced reactivity towards tuberculin test [13] . On the contrary, morphine can also increase the phagocytosis of Mycobacterium tuberculosis by microglial cells [14] . Recently, we have reported the protective effects of morphine in M. tuberculosis infection in mice and macrophages [15] . The protective role of opioids may result from macrophage activation at lower concentrations leading to enhanced production of cytokines and nitric oxide (NO) [3, [8] [9] [10] [11] 15] . These molecules play a crucial role in intramacrophage and in vivo killing of mycobacteria as well [15] [16] [17] [18] . Here, we report the effect of morphine on survival of M. smegmatis in murine and macrophage models of TB.
Materials and methods

Animals
Swiss albino mice (20 ± 2 g), obtained from Central Animal Facility of the institute, were maintained in 12 h light/dark cycle and provided food and water ad libitum. All studies were carried out as per protocol approved by Institutional Animal Ethics Committee (IAEC) prior to experimentation.
Bacteria and infection
M. smegmatis was obtained from Tuberculosis Research
Centre, Chennai, India. The bacteria were grown in Middlebrook 7H9 medium (HiMedia, India) supplemented with 10% ADC (HiMedia). Log phase cultures were centrifuged and washed twice with sterile saline. The cell suspension was adjusted to McFarland standard no. 5 (1 × 10 7 bacteria/ml) and sonicated (20 KHz, 10 seconds, 10 cycles; Bandelin, Germany). Mice were infected intravenously with 0.1 ml of the bacterial suspension. The size of inoculum was confi rmed by plating 10-fold serial dilutions (prepared in saline) on Middlebrook 7H10 agar medium (HiMedia) with 10% ADC supplement followed by CFU enumeration after 3-4 days of incubation at 37°C in 5% CO 2 atmosphere.
Drugs
Morphine was obtained from Government Opium and Alkaloid Factory, Ghazipur, India. Naloxone and aminoguanidine (AG) were obtained from Sigma, USA. The drugs were dissolved in sterile saline.
Drug treatment
M. smegmatis-infected mice were administered 5, 50 and 100 mg/kg morphine following two dosage regimens. In single dose regimen, morphine was administered on day 0 of infection (3 h post-infection). In the two-dose regimen, morphine was administered on day 0 (3 h post-infection) and day +3 of infection (n=10 per group). Control groups were administered saline on similar schedule.
CFU enumeration
M. smegmatis-infected mice were sacrifi ced on day +7 of infection by cervical dislocation. Lungs and spleen were homogenized in saline and 10-fold serial dilutions were plated on Middlebrook 7H10 medium with 10% ADC supplement. CFUs were enumerated after 3-4 days of incubation at 37°C in 5% CO 2 atmosphere.
Spleen and lung pathology
On the day of sacrifi ce, the spleen and lungs were removed. The organ pathologies were determined as described earlier [15] .
Intramacrophage killing
Elicited peritoneal macrophages were harvested from mice as described elsewhere [9] . Adherent macrophage monolayers were infected with M. smegmatis as described elsewhere [15] and incubated with different concentrations of morphine (1 pM to 100 μM) in presence or absence of 10 μM naloxone and 100 μM AG. Following drug treatment, M. smegmatis-infected macrophages were lysed on day 0, day +1 and day +3 as described elsewhere [15] . Tenfold serial dilutions of macrophage lysates were plated on Middlebrook 7H10 medium supplemented with 10% ADC and CFUs were enumerated after 3-4 days of incubation at 37°C in 5% CO 2 atmosphere.
Direct antimycobacterial activity of morphine
The direct antimycobacterial activity of morphine against M. smegmatis was assessed by broth dilution method [19] .
Statistical analysis
CFU counts were converted to logarithmic scale and evaluated by one-way ANOVA using Sigma Stat program.
Results
Effect of morphine treatment on lung CFU counts
Mice infected with M. smegmatis were administered morphine following two regimens. In the single dose regimen (day 0), low dose of morphine (5 mg/kg) had no effect on bacterial load in lungs as compared to salinetreated control. However, treatment with higher doses of 50 and 100 mg/kg morphine resulted in signifi cant (P <0.01) reduction in bacterial load in lungs (data not shown). Similarly, administration of two doses of morphine (day 0 and day +3) showed a dose-dependent reduction in bacterial load in lungs (Fig. 1) . Further, the bacterial load was not signifi cantly different in the two dosage regimens.
Effect of morphine treatment on spleen CFU counts
In the single dose regimen, administration of low dose of morphine (5 mg/kg) had no effect on bacterial load in spleen as compared to saline-treated group. However, treatment with higher doses of morphine (50 and 100 mg/kg) resulted in signifi cant (P <0.05) reduction in spleen bacterial load (data not shown). Similarly, in the two dose regimen, 50 and 100 mg/kg morphine resulted in signifi cant (P <0.01) reduction in bacterial load (Fig. 1) , whereas low dose of morphine (5 mg/kg) had no effect. Further, no signifi cant difference was observed in suppression of infection between the two regimens.
Spleen and lung pathology
On the day of sacrifi ce, spleen weights and gross lung pathology of M. smegmatis-infected mice were recorded. A direct correlation was observed between the weight and number of CFUs in the spleen of mice treated with single (data not shown) and two (Table 1 ) doses of morphine. There was no signifi cant difference in spleen weights and CFU counts in either of the treatment regimens.
Effect of morphine on intramacrophage killing
The concentration-dependent effect of morphine was studied in M. smegmatis-infected macrophages. High concentration of morphine (100 μM) showed signifi cant (P <0.05) reduction in intramacrophage bacterial load. However, lower concentrations of morphine were ineffective (Fig. 2) . The effects of morphine were abrogated by naloxone (P <0.01) (Fig. 3) and AG (Fig.4) .
Direct antimycobacterial activity of morphine
Different concentrations of morphine (1pM to 100 μM) lacked any direct antimycobacterial activity against M. smegmatis in the broth dilution assay ( Table 2) .
Discussion
Opioids can modulate the in vivo course of parasitic and bacterial infections in a dose-dependent manner [8, 9, 11, 15, 20] . In the present study, we report, apparently M. smegmatis-infected mice were treated with indicated doses of morphine on day 0 and day +3 and sacrifi ced to determine bacterial load in lungs and spleen as described in Materials and methods. * P<0.01 as compared to control for the fi rst time, dose-dependent modulation of M. smegmatis infection in vitro and in vivo. The results of this study indicate that morphine can modulate the in vivo course of M. smegmatis infection in mice as evident from bacterial load in the target organs. Low dose of morphine (5 mg/kg) was found to be ineffective (P>0.05) while higher doses (50 and 100 mg/kg) showed a signifi cant (P<0.01) suppression of infection. Further, bacterial load in control group was higher in spleen as compared to lungs which is a characteristic feature of non-virulent strains of Mycobacterium [21, 22] .
Macrophages are the key cells responsible for in vivo killing of mycobacteria. Hence, we studied the intramacrophage killing of M. smegmatis at various concentrations of morphine. Morphine, at 100 μM concentration, showed a signifi cant reduction in intramacrophage survival of M. smegmatis, whereas lower concentrations of morphine did not show a signifi cant change (P>0.05) (Figure 2 ). Morphine lacked direct activity against M. smegmatis up to 100 μM concentration (Table 2) suggesting that the intramacrophage and in vivo killing of M. smegmatis is not due to the direct effect of morphine on the bacterium. Further, the intramacrophage killing of M. smegmatis was abrogated by naloxone (Fig. 3) indicating the role of naloxone-sensitive opioid receptors in the killing effects of morphine. These results support the proposition that morphine can modulate the intramacrophage survival of M. smegmatis by modulation of the immune system.
The mechanisms involved in immunomodulatory effects of opioids are not well characterized. Opioids form a part of a complex network of common ligands and receptors, shared by the immune system and central nervous system. Opioids exert their effects by binding to their specifi c receptors expressed by the immune cells [2, 23] or in the central nervous system [4, 5] which account for their direct and M. smegmatis-infected macrophages were incubated with 100 μM morphine in presence or absence of 100 μM AG and lysed on day 0, +1 and +3 to determine intramacrophage killing as described in Materials and methods. Error bars are not shown for clarity. * P<0.01 as compared to control ** P<0.05 as compared to control indirect immunomodulatory effects, respectively. Apart from the classical opioid receptors, atypical opioid receptors are also expressed by immune cells [24, 25] . Macrophages are important cellular target for opioids. Morphine can alter normal macrophage functions such as phagocytic activity and burst phenomena and may account for the immunosuppressive effects of morphine; however, morphine can also exhibit immunostimulant effects [10] . Macrophages are the key cells involved in resistance to M. tuberculosis and other related species. However, these bacteria reside and divide in the very cells that are responsible for their killing, i.e. macrophages. The intracellular killing of bacteria is achieved by production of NO by the enzyme nitric oxide synthase (NOS). NOS activation is, in turn, under the control of cytokines like interferon-γ and tumor necrosis factor-α. Morphine can alter the generation of NO through modulation of NOS activity [3, 8, 26] or cytokine production by immune cells [8, 10] , leading to alteration in host susceptibility to infections. In the present study, the effect of dexamethasone (an immunosuppresant) and AG (NOS inhibitor; Fig. 4 ) on intramacrophage killing of M. smegmatis was studied. The intramacrophage killing of M. smegmatis by morphine was abrogated in presence of dexamethasone (data not shown) and AG (Fig. 4) . Further, the intracellular killing was found to be dependent on the nitrite concentration in culture supernatants of morphinetreated, M. smegmatis-infected mouse peritoneal macrophages (data not shown). These results suggest that morphine can stimulate the macrophages, possibly involving induction of NOS, and result in reduced intramacrophage survival of M. smegmatis.
In conclusion, morphine can modulate the in vitro and in vivo survival of M. smegmatis. Previous reports on immunomodulatory activity of morphine have demonstrated the protective effects of low doses of morphine in experimental models of malaria [11] , leishmania [8, 9] and TB [15] . However, relatively higher doses of morphine were found to be protective in M. smegmatis infection in vivo. Further, higher concentrations of morphine were required to activate M. smegmatis-infected macrophages. Hence, there can not be a fi xed dose of morphine showing protective effect against infections. The protective dose may depend on the nature of infection and the immune status of the host. Further studies are required to elucidate the mechanisms responsible for differential effects of morphine in different infections. Table 2 The direct antimycobacterial activity of morphine was determined by broth dilution method. Log-phase cultures of M. smegmatis were incubated with indicated concentrations of morphine for 72 hours and growth was monitored spectrophotometrically at 600 nm and confi rmed by plating on Middlebrook 7H10 medium. * P<0.01 as compared to control
